Clinical Trial Update: Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

An ongoing Phase 2 clinical trial evaluating SIBP-03 for head and neck squamous cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• SIBP-03

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING